Results 131 to 140 of about 10,019 (188)

Apical Sparing and Granular Sparkling: Not Everything that Glitters Is Cardiac Amyloidosis. [PDF]

Arq Bras Cardiol
Barros APM, Romero CE, Cardoso JN, Fernandes F, Hotta VT.   +4 more
europepmc   +1 more source

Clinical Practice Guidelines for diagnosis of amyloidosis: Part 1/3 Year 2020 [PDF]

Rev Fac Cien Med Univ Nac Cordoba, 2021
Posadas Martinez ML, Aguirre MA, Belziti C, Brouet E, Auteri MA, Forte AL, Greloni G, Marciano S, Matoso MD, Perez de Arenaza D, Pitzus AE, Rugiero M, Saez S, Sorroche P, Tomei M, Zinser B, Peuchot V, Nucifora E.   +17 more
europepmc   +1 more source

Patisiran Treatment in the Brazilian Subpopulation of the Phase 3 APOLLO-B Study in Transthyretin Amyloidosis with Cardiomyopathy: Post Hoc Analysis. [PDF]

Arq Bras Cardiol
Mesquita CT, Schwartzmann P, Correia EB, Simões MV, Biolo A, Duque DR, Jay PY, Fernandes F.   +7 more
europepmc   +1 more source

The Complex Puzzle of Hypertrophic Phenotype: A Practical Approach for the Clinician. [PDF]

Arq Bras Cardiol
Felix ADS, Barberato SH, Melo MDT, Rosa SA, Cardim N.   +4 more
europepmc   +1 more source

The heart-brain team: neurocardiology [PDF]

Arch Cardiol Mex, 2020
Jiménez-Ruiz A, Ruiz-Sandoval JL, Araiza-Garaygordobil D, Sierra-Lara D.   +3 more
europepmc   +1 more source

Scintigraphic and Echocardiographic Study of Patients with Pathogenic or Probably Pathogenic Variants of the TTR Gene without Overt Cardiac Involvement. [PDF]

Arq Bras Cardiol
Silva TO, Darzé ES, Costa MM, José Junior L, Ximenes AAB, Fernandes F, Rocha MS, Noya-Rabelo MM, Ritt LEF.   +8 more
europepmc   +1 more source

Renal tubular acidosis in hereditary transthyretin amyloidosis (ATTRv). [PDF]

J Bras Nefrol
Fernandes PC, Silva MDD, Waddington-Cruz M, Gomes CP.   +3 more
europepmc   +1 more source

Post-COVID-19 condition: a sex-based analysis of clinical and laboratory trends. [PDF]

Front Med (Lausanne)
Delfino C, Poli MC, Vial C, Vial PA, Martínez G, Riviotta A, Arbat C, Mac-Guire N, Hoppe J, Carvajal C, Muñoz Venturelli P.   +10 more
europepmc   +1 more source

Doença de Alzheimer: Imunoterapia contra Amiloide Beta

, 2014
Alois Alzheimer first described alzheimer’s disease little more than 100 years ago. This condition is the most common cause of dementia, affecting around 30 million people worldwide. This pathology is to become an epidemic problem, it is estimated that by 2050 the annual incidence reaches a million people just in the United States.
openaire   +1 more source